Format
Sort by

Send to

Choose Destination

Search results

Items: 9

1.

Bexarotene targets autophagy and is protective against thromboembolic stroke in aged mice with tauopathy.

Huuskonen MT, Loppi S, Dhungana H, Keksa-Goldsteine V, Lemarchant S, Korhonen P, Wojciechowski S, Pollari E, Valonen P, Koponen J, Takashima A, Landreth G, Goldsteins G, Malm T, Koistinaho J, Kanninen KM.

Sci Rep. 2016 Sep 14;6:33176. doi: 10.1038/srep33176.

2.

Retinoids and motor neuron disease: Potential role in amyotrophic lateral sclerosis.

Riancho J, Berciano MT, Ruiz-Soto M, Berciano J, Landreth G, Lafarga M.

J Neurol Sci. 2016 Jan 15;360:115-20. doi: 10.1016/j.jns.2015.11.058. Review.

PMID:
26723986
3.

ABCA1 is Necessary for Bexarotene-Mediated Clearance of Soluble Amyloid Beta from the Hippocampus of APP/PS1 Mice.

Corona AW, Kodoma N, Casali BT, Landreth GE.

J Neuroimmune Pharmacol. 2016 Mar;11(1):61-72. doi: 10.1007/s11481-015-9627-8.

PMID:
26175148
4.

Omega-3 Fatty Acids Augment the Actions of Nuclear Receptor Agonists in a Mouse Model of Alzheimer's Disease.

Casali BT, Corona AW, Mariani MM, Karlo JC, Ghosal K, Landreth GE.

J Neurosci. 2015 Jun 17;35(24):9173-81. doi: 10.1523/JNEUROSCI.1000-15.2015.

5.

Nuclear receptors license phagocytosis by trem2+ myeloid cells in mouse models of Alzheimer's disease.

Savage JC, Jay T, Goduni E, Quigley C, Mariani MM, Malm T, Ransohoff RM, Lamb BT, Landreth GE.

J Neurosci. 2015 Apr 22;35(16):6532-43. doi: 10.1523/JNEUROSCI.4586-14.2015.

6.

Bexarotene reduces network excitability in models of Alzheimer's disease and epilepsy.

Bomben V, Holth J, Reed J, Cramer P, Landreth G, Noebels J.

Neurobiol Aging. 2014 Sep;35(9):2091-5. doi: 10.1016/j.neurobiolaging.2014.03.029.

7.

Response to comments on "ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models".

Landreth GE, Cramer PE, Lakner MM, Cirrito JR, Wesson DW, Brunden KR, Wilson DA.

Science. 2013 May 24;340(6135):924-g. doi: 10.1126/science.1234114.

8.

In vivo measurement of apolipoprotein E from the brain interstitial fluid using microdialysis.

Ulrich JD, Burchett JM, Restivo JL, Schuler DR, Verghese PB, Mahan TE, Landreth GE, Castellano JM, Jiang H, Cirrito JR, Holtzman DM.

Mol Neurodegener. 2013 Apr 19;8:13. doi: 10.1186/1750-1326-8-13.

9.

ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models.

Cramer PE, Cirrito JR, Wesson DW, Lee CY, Karlo JC, Zinn AE, Casali BT, Restivo JL, Goebel WD, James MJ, Brunden KR, Wilson DA, Landreth GE.

Science. 2012 Mar 23;335(6075):1503-6. doi: 10.1126/science.1217697.

Items per page

Supplemental Content

Loading ...
Support Center